,"Author: Ashton-Rickardt, Philip G.",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 12 (Of the 22 documents considered for the h-Index, 12 have been cited at least 12 times.)",,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,2468,121,121,242,53,2763
2008,"CD95 signaling deficient mice with a wild-type hematopoietic system are prone to hepatic neoplasia","Park S.-M., Rajapaksha T.W., Zhang M., Sattar H.A., Fichera A., Ashton-Rickardt P.G., Peter M.E.",13608185,"Apoptosis",13, 1,0,0,2,2,1,3
2007,"Serine protease inhibitor 6-deficient mice have increased neutrophil immunity to Pseudomonas aeruginosa","Zhang M., Belaaouaj A., Ashton-Rickardt P.G., Liu N., Park S.-M., Wang Y., Byrne S., Murmann A.E., Bahr S., Peter M.E., Olson S.T.",00221767,"Journal of Immunology",179, 7,0,0,1,1,0,1
2007,"Studying T-cell repertoire selection using fetal thymus organ culture","Ashton-Rickardt P.G.",10643745,"Methods in Molecular Biology",380, ,0,0,0,0,0,0
2007,"Differential survival of cytotoxic T cells and memory cell precursors","Zhang M., Byrne S., Liu N., Wang Y., Oxenius A., Ashton-Rickardt P.G.",00221767,"Journal of Immunology",178, 6,0,1,3,4,4,8
2006,"Serine Protease Inhibitor 6 Protects Cytotoxic T Cells from Self-Inflicted Injury by Ensuring the Integrity of Cytotoxic Granules","Zhang M., Park S.-M., Wang Y., Shah R., Liu N., Murmann A.E., Wang C.-R., Peter M.E., Ashton-Rickardt P.G.",10747613,"Immunity",24, 4,3,13,7,20,3,26
2005,"The granule pathway of programmed cell death","Ashton-Rickardt P.G.",10408401,"Critical Reviews in Immunology",25, 3,4,9,1,10,2,16
2004,"A license to remember","Ashton-Rickardt P.G.",15292908,"Nature Immunology",5, 11,1,3,1,4,2,7
2004,"A role for the granzyme B inhibitor serine protease inhibitor 6 in CD8 + memory cell homeostasis","Phillips T., Opferman J.T., Shah R., Liu N., Froelich C.J., Ashton-Rickardt P.G.",00221767,"Journal of Immunology",173, 6,14,6,6,12,0,26
2004,"Serine protease inhibitor 2A is a protective factor for memory T cell development","Liu N., Phillips T., Zhang M., Wang Y., Opferman J.T., Shah R., Ashton-Rickardt P.G.",15292908,"Nature Immunology",5, 9,19,5,5,10,2,31
2004,"Serine protease inhibitor 2A inhibits caspase-independent cell death","Liu N., Wang Y., Ashton-Rickardt P.G.",00145793,"FEBS Letters",569, 1-3,6,2,4,6,4,16
2003,"NF-?B protects from the lysosomal pathway of cell death","Liu N., Lee J.C., Peter M.E., Froelich C.J., Franzoso G., Ashton-Rickardt P.G., Raja S.M., Zazzeroni F., Metkar S.S., Shah R., Zhang M., Wang Y., Bromme D., Russin W.A.",02614189,"EMBO Journal",22, 19,33,6,7,13,5,51
2003,"A critical role for NF-?B transcription factors in the development of CD8+ memory-phenotype T cells","Hettmann T., Opferman J.T., Leiden J.M., Ashton-Rickardt P.G.",01652478,"Immunology Letters",85, 3,5,0,0,0,1,6
2003,"The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency","Hirst C.E., Buzza M.S., Bird C.H., Warren H.S., Cameron P.U., Zhang M., Ashton-Rickardt P.G., Bird P.I.",00221767,"Journal of Immunology",170, 2,39,9,5,14,2,55
2001,"Suicide induced by cytolytic activity controls the differentiation of memory CD8+ T lymphocytes","Opferman J.T., Ober B.T., Narayanan R., Ashton-Rickardt P.G.",09538178,"International Immunology",13, 4,13,1,1,2,1,16
2000,"Affinity of thymic self-peptides for the TCR determines the selection of CD8+ T lymphocytes in the thymus","Ober B.T., Hu Q., Opferman J.T., Hagevik S., Chiu N., Wang C.-R., Ashton-Rickardt P.G.",09538178,"International Immunology",12, 9,12,0,0,0,0,12
1999,"What keeps a resting T cell alive?","Thompson C.B., Schumacker P.T., Vander Heiden M.G., Rathmell J.C., Frauwirth K.A., Lindsten T., Rudin C.M., Opferman J.T., Ashton-Rickardt P.G., Harris M.H., Chandel N.S.",00917451,"Cold Spring Harbor Symposia on Quantitative Biology",64, ,2,0,0,0,0,2
1999,"Memory T lymphocytes","Ashton-Rickardt P.G., Opferman J.T.",1420682X,"Cellular and Molecular Life Sciences",56, 1-2,4,0,0,0,0,4
1999,"Erratum: Linear differentiation of cytotoxic effectors into memory T lymphocytes (Science (March 12, 1999) (1745))","Opferman J.T., Ashton-Rickardt P.G.",00368075,"Science",283, 5410,0,0,0,0,0,0
1999,"Linear differentiation of cytotoxic effectors into memory T lymphocytes","Opferman J.T., Ober B.T., Ashton-Rickardt P.G.",00368075,"Science",283, 5408,199,12,15,27,6,232
1998,"Long-term T cell memory requires the surface expression of self-peptide/major histocompatibility complex molecules","Markiewicz M.A., Girao C., Opferman J.T., Sun J., Hu Q., Agulnik A.A., Bishop C.E., Thompson C.B., Ashton-Rickardt P.G.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",95, 6,125,5,3,8,2,135
1997,"Limits to the Differential Avidity Model of T Cell Selection in the Thymus","Girao C., Hu Q., Sun J., Ashton-Rickardt P.G.",00221767,"Journal of Immunology",159, 9,37,0,0,0,0,37
1997,"Specific recognition of thymic self-peptides induces the positive selection of cytotoxic T lymphocytes","Hu Q., Bazemore Walker C.R., Girao C., Opferman J.T., Sun J., Shabanowitz J., Hunt D.F., Ashton-Rickardt P.G.",10747613,"Immunity",7, 2,70,1,1,2,1,73
1995,"Presentation of endogenous viral proteins in association with major histocompatibility complex class II: On the role of intracellular compartmentalization, invariant chain and the TAP transporter system","Oxenius A., Bachmann M.F., Ashton-Rickardt P.G., Tonegawa S., Zinkernagel R.M., Hengartner H.",00142980,"European Journal of Immunology",25, 12,52,6,4,10,1,63
1995,"Increase in positive selection of CD8+ T cells in TAP1-mutant mice by human ?2-microglobulin transgene","Van Santen H.M., Woolsey A., Ashton Rickardt P.G., Van Kaer L., Baas E.J., Berns A., Tonegawa S., Ploegh H.L.",00221007,"Journal of Experimental Medicine",181, 2,23,0,1,1,0,24
1995,"Differential reactivity of residual CD8+ T lymphocytes in TAP1 and ?2-microglobulin mutant mice","Ljunggren H.-G., Van Kaer L., Ashton-Rickardt P.G., Tonegawa S., Ploegh H.L.",00142980,"European Journal of Immunology",25, 1,32,0,0,0,0,32
1994,"Altered peptidase and viral-specific T cell response in LMP2 mutant mice","Van Kaer L., Ashton-Rickardt P.G., Eichelberger M., Gaczynska M., Nagashima K., Rock K.L., Goldberg A.L., Doherty P.C., Tonegawa S.",10747613,"Immunity",1, 7,209,8,6,14,8,231
1994,"A differential-avidity model for T-cell selection","Ashton-Rickardt P.G., Tonegawa S.",01675699,"Immunology Today",15, 8,179,4,6,10,0,189
1994,"A differential-avidity model for T-cell selection","Ashton-Rickardt P.G., Tonegawa S.",14714906,"Trends in Immunology",15, 8,0,0,3,3,0,3
1994,"Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice","Aldrich C.J., Ljunggren H.-G., Van Kaer L., Ashton-Rickardt P.G., Tonegawa S., Forman J.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",91, 14,26,0,0,0,0,26
1994,"Evidence for a differential avidity model of T cell selection in the thymus","Ashton-Rickardt P.G., Bandeira A., Delaney J.R., Van Kaer L., Pircher H.-P., Zinkernagel R.M., Tonegawa S.",00928674,"Cell",76, 4,454,7,9,16,3,473
1994,"Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator","Schumacher T.N.M., Ploegh H.L., Kantesaria D.V., Heemels M.-T., Ashton-Rickardt P.G., Shepherd J.C., Fruh K., Yang Y., Peterson P.A., Tonegawa S.",00221007,"Journal of Experimental Medicine",179, 2,119,0,3,3,0,122
1994,"Positive selection of self- and alloreactive CD8+ T cells in Tap-1 mutant mice","Aldrich C.J., Ljunggren H.G., Van Kaer L., Ashton-Rickardt P.G., Tonegawa S., Forman J.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",91, 14,16,1,1,2,0,18
1993,"The role of peptide in the positive selection of CD8+T cells in the thymus","Ashton-Rickardt P.G.",01656090,"Thymus",22, 2,5,0,1,1,0,6
1993,"Incorrect attribution of peptide source","Shepherd J.C., Schumacher T.N.M., Ashton-Rickardt P.G., Imaeda S., Ploegh H.L., Janeway Jr. C.A., Tonegawa S.",00928674,"Cell",75, 4,0,0,0,0,0,0
1993,"Peptide contributes to the specificity of positive selection of CD8+ T cells in the thymus","Ashton-Rickardt P.G., Van Kaer L., Schumacher T.N.M., Ploegh H.L., Tonegawa S.",00928674,"Cell",73, 5,159,2,2,4,0,163
1993,"TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective","Shepherd J.C., Schumacher T.N.M., Ashton-Rickardt P.G., Imaeda S., Ploegh H.L., Janeway Jr. C.A., Tonegawa S.",00928674,"Cell",74, 3,180,4,3,7,0,187
1993,"Incorrect attribution of peptide source","Eisen H.N., Ploegh H.L., Janeway Jr. C.A., Tonegawa S., Tsomides T., Udaka K., Walden P., Fukusen N., Shepherd J.C., Schumacher T.N.M., Ashton-Rickardt P.G., Imaeda S.",00928674,"Cell",75, 4,0,0,0,0,0,0
1993,"Repertoire-determining role of peptide in the positive selection of CD8+ T cells","Ashton-Rickardt P.G., Van Kaer L., Schumacher T.N.M., Ploegh H.L., Tonegawa S.",01052896,"Immunological Reviews",, 135,6,0,0,0,0,6
1992,"TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells","Van Kaer L., Ashton-Rickardt P.G., Ploegh H.L., Tonegawa S.",00928674,"Cell",71, 7,335,8,17,25,2,362
1991,"MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer","Ashton-Rickardt P.G., White R., Nakamura Y., Wyllie A.H., Bird C.C., Dunlop M.G., Steel C.M., Morris R.G., Piris J., Romanowski P., Wood R.",09509232,"Oncogene",6, 10,29,1,1,2,0,31
1989,"Mutants of the hepatitis B virus surface antigen that define some antigenically essential residues in the immunodominant a region","Ashton-Rickardt P.G., Murray K.",01466615,"Journal of Medical Virology",29, 3,22,3,1,4,1,27
1989,"Mutations that change the immunological subtype of hepatitis B virus surface antigen and distinguish between antigenic and immunogenic determination","Ashton-Rickardt P.G., Murray K.",01466615,"Journal of Medical Virology",29, 3,15,3,0,3,0,18
1989,"Genetic engineering applied to the development of vaccines.","Murray K., Stahl S., Ashton-Rickardt P.G.",09628436,"Philosophical transactions of the Royal Society of London. Series B: Biological sciences",324, 1224,0,0,0,0,0,0
1989,"High frequency of APC loss in sporadic colorectal carcinoma due to breaks clustered in 5q21-22","Ashton-Rickardt P.G., Dunlop M.G., Nakamura Y., Morris R.G., Purdie C.A., Steel C.M., Evans H.J., Bird C.C., Wyllie A.H.",09509232,"Oncogene",4, 10,21,1,1,2,2,25
